Status:
COMPLETED
Comparison of Neo-adjuvant Weekly Paclitaxel With or Without Carboplatin in Early Breast Cancer
Lead Sponsor:
Tao OUYANG
Conditions:
Breast Cancer
Eligibility:
FEMALE
18-65 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to determine whether neo-adjuvant weekly paclitaxel with carboplatin is better than paclitaxel alone in efficiency and safety in early breast cancer, and to explore whethe...
Eligibility Criteria
Inclusion
- female patients between 18 and 65 years old
- pathological diagnosed invasive breast cancer; medium and high risk primary breast cancer according to St. Gallen 2007
- able and willing to give consent to participate in the study
Exclusion
- pregnant or lactating females
- previous treatment for breast cancer
- other tumor history
- instable complication (e.g., myocardial infarction within 6 months, arrhythmia, unstable diabetes, hypercalcemia) or uncontrolled infection
- allergy history to similar drugs
- concurrent disease or condition that would make the patient inappropriate for study participation
- resist to participate in the study
Key Trial Info
Start Date :
July 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
148 Patients enrolled
Trial Details
Trial ID
NCT00919880
Start Date
July 1 2009
End Date
December 1 2010
Last Update
August 15 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Cancer Hospital Breast Center
Beijing, Beijing Municipality, China